Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.
Ramaekers JG, Reckweg JT, Mason NL
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (0)
No references identified in the available metadata. This does not establish that none exist.
Cited by — these papers cite this paper (2)
- The New Mexico Medical Psilocybin Act and current trends in the United States psychedelic policy 2026-10-01 · Expand citations
- “To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group Therapy 2025-08-25 · Expand citations